Evidence map›Paper›PMID 21242333›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2011

Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data.

Patrick G Pilie, Catherine Ibarra-Drendall, Michelle M Troch, Gloria Broadwater, William T Barry, Emanuel F Petricoin, Julia D Wulfkuhle, Lance A Liotta, Siya Lem, Joseph C Baker and 11 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Tumor mechanics and metabolic dysfunction.Free radical biology & medicine · 2015
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Patrick G PilieDuke University Medical Center, Box 2628, Durham, NC 27710, USA.
Catherine Ibarra-Drendall
Michelle M Troch
Gloria Broadwater
William T Barry
Emanuel F Petricoin
Julia D Wulfkuhle
Lance A Liotta
Siya Lem
Joseph C Baker
April Stouder
Anne C Ford
Lee G Wilke
Carola M Zalles
Priya Mehta
Jamila Williams
Melanie Shivraj
Zuowei Su
Joseph Geradts
Dihua Yu
Victoria L Seewaldt

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Tension-Stat3-miR-mediated metastasisR01CA192914 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SEEWALDT, VICTORIA L., WEAVER, VALERIE MARIE · 2015 to 2019
$2.9M
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECsR01CA088799 · NCI · DUKE UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2001 to 2010
$2.7M
KCNK9 Imprinting in Breast Cancer Progression and MetastasisR01CA155664 · NCI · DUKE UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2011 to 2015
$1.8M
Targeted Chemoprevention of Breast Cancer: From the Bench to Clinical TestingR01CA158668 · NCI · DUKE UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2012 to 2016
$1.7M
p53 loss in HMECs: a model of breast cancer preventionR01CA098441 · NCI · DUKE UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2003 to 2007
$1.5M
Molecular markers of breast cancer risk and preventionR01CA114068 · NCI · DUKE UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2006 to 2010
$1.3M
NCI NIH HHS 3 P30 CA014236-32S1NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA088799NCI NIH HHS R01 CA098441NCI NIH HHS R01 CA114068NCI NIH HHS R01CA114068NCI NIH HHS R01 CA155664NCI NIH HHS R01 CA158668NCI NIH HHS R01 CA192914NCI NIH HHS R01CA88799
6 · The paper itself

Abstract

backgroundObesity is a well-established risk factor for cancer, accounting for up to 20% of cancer deaths in women. Studies of women with breast cancer have shown obesity to be associated with an increased risk of dying from breast cancer and increased risk of developing distant metastasis. While previous studies have focused on differences in circulating hormone levels as a cause for increased breast cancer incidence in postmenopausal women, few studies have focused on potential differences in the protein expression patterns of mammary epithelial cells obtained from obese versus nonobese women.

methodsProtein expression was assessed by reverse-phase protein microarray in mammary epithelial cells from 31 random periareolar fine needle aspirations performed on 26 high-risk women.

resultsIn this pilot and exploratory study, vimentin (unadjusted P=0.028) expression was significantly different between obese and nonobese women.

conclusionsVimentin is integral both to adipocyte structure and function and to the epithelial-to-mesenchymal transition needed for cancer cell metastasis. Further research is needed to confirm this finding and determine the possible effects of the adipocyte microenvironment on the initiation and progression of breast cancer in high-risk women. IMPACT: Differential protein expression patterns obtained from a future expanded study may serve to elaborate the underlying pathology of breast cancer initiation and progression in obese women and identify potential biomarkers of response to preventative interventions such as dietary changes and exercise.

Indexed as

AdultAgedBiomarkers, TumorBiopsy, Fine-NeedleBody Mass IndexBreast NeoplasmsEpithelial CellsFemaleHumansImmunohistochemistryMammary Glands, HumanMiddle AgedObesityPilot ProjectsProtein Array AnalysisRetrospective StudiesBiomarkers, TumorVimentin

Identifiers

PMID21242333
PMCPMC3051011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.